Marshall Wace
THRD

Marshall Wace’s Third Harmonic Bio THRD Stock Holding History

Marshall Wace’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,198
Closed -$289K – 2951
2024
Q2 		$289K Buy
+22,198
New +$275K ﹤0.01% 2173
2022
Q4 		– Sell
-58,465
Closed -$1.11M – 3419
2022
Q3 		$1.11M Buy
+58,465
New +$1.05M ﹤0.01% 2359

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Marshall Wace's THRD Position: Q3 2024 in Review

Marshall Wace sold out of Third Harmonic Bio (THRD) in Q3 2024, closing a stake of 22,198 shares — an estimated $289K sold.

Marshall Wace first reported a position in THRD in Q3 2022 and held it in 2 quarters. The position peaked at $1.11M in Q3 2022. 84 funds tracked by Wall St. Rank hold THRD as of Q3 2024.

  • Marshall Wace reported no remaining Third Harmonic Bio position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 22,198 Third Harmonic Bio shares in Q3 2024, an estimated $289K.
  • Marshall Wace first reported a position in Third Harmonic Bio in Q3 2022 and held it in 2 quarters.
  • Marshall Wace's Third Harmonic Bio position peaked at $1.11M in Q3 2022.
  • 84 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.